Frank Laukien; Chairman of the Board, President, Chief Executive Officer; Bruker Corp Gerald Herman; Chief Financial Officer, Executive Vice President; Bruker Corp Good day, and welcome to the Bruker ...

Corporation reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. Revenue also exceeded projections, ...

Iridium Communications Inc. ("Iridium") today reported financial results for the fourth quarter and full-year 2024 and issued its full-year 2025 guidance. Net income was $36.3 million, or $0.32 per ...

Achieved $479.0 million in AYVAKIT® (avapritinib) global net product revenues in 2024, including $144.1 million in the fourth quarter -- -- Anticipate global AYVAKIT net product revenue of ...

Browse 400 market data Tables and 50 Figures spread through 250 Pages and in-depth TOC on "Mass Spectrometry Market by ...

Wells Fargo analyst Brandon Couillard maintained a Buy rating on Avantor (AVTR – Research Report) today and set a price target of $28.00. The ...

Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This ...

CNW/ - Solid Hook Inc., a leader in machinery moving and equipment transportation, successfully collaborated with the University of Toronto to modernize ...

Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine ...

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales reorganization and grow base of industry users.

Bruker had a net margin of 9.41% and a return on equity of 21.52%. The firm had revenue of $864.40 million for the quarter, compared to analyst estimates of $866.46 million.

Novel technologies were added when developing an innovative vivarium for a prominent Boston cancer research organization to enhance the facility’s overall effectiveness, value, and design program.